博狗体育博狗体育
We are focussed on developing robust and efficient fermentation and purification processes to maximise product quality and yield.
We accomplish this through use of research study designs and scale-down models to optimise process conditions that can be translated through scale-up strategies to cGMP manufacturing. Our expertise in up-stream and down-stream process development is complemented by comprehensive analytical support, a range of process scale options and state-of-the-art technologies.
Compiling a robust data package that defines the characteristics of a biotherapeutic agent for regulatory and process design purposes is essential. We develop methods in parallel with up-stream and down-stream activities to evaluate product quality and purity. Our experience, agility and adaptability allow us to develop timely solutions to complex problems.
This learning not only influences the manufacturing process but allows scientific sound formulation strategies to be developed. Our experience in liquid and lyophilised dosage forms for injectable delivery systems ensures a high-quality stable product, that is safe and efficacious is delivered.
We form integrated teams to facilitate translational activities between Development and Pharmaceutical cGMP areas. Our flexible work ethic promotes engagement of Production and Quality Control staff during late stage Development activities, followed by a man-in-plant strategy during transfer to Production or Quality Control areas. The combination of skills and experience across the organisation is complemented by use of paper based systems which ensure that process controls, build up through extensive Development records, are translated to Production and QC Batch Manufacturing Records and SOPs.
Registered in England and Wales, company number 博狗体育. Registered office at 博狗体育 博狗体育 博狗体育, Porton 博狗体育, Salisbury, Wiltshire SP4 0JG. VAT number is GB 206 6518 18.